All Posts

The Biomedical Advanced Research and Development Authority’s (BARDA) Division of Research, Innovation, and Ventures (DRIVe) has recently announced a new area of interest (AOI) under its Broad Agency Announcement (BAA). This competitive solicitation aims to foster the development of advanced microphysiological models of human tissues, with a particular emphasis on modeling components of the immune […]

In an announcement that promises to shape the future of semiconductor manufacturing in the United States, the National Institute of Standards and Technology (NIST) has released a summary of responses to its Request for Information (RFI) concerning semiconductor-related manufacturing. In its quest to understand and respond to the challenges and opportunities in the domestic semiconductor

DOE Announces $187 Million to Ensure Widespread and Accelerated Electrification in America The U.S. Department of Energy (DOE) has recently made an announcement that aims to propel the widespread and accelerated electrification of America. The DOE has allocated a substantial $187 million budget to support initiatives that will promote the adoption of electric technologies across

EverGlade Consulting Funding Alert – Revolutionizing Osteoarthritis Treatment: The ARPA-H NITRO Program The Advanced Research Projects Agency for Health (ARPA-H) has issued a Broad Agency Announcement (BAA) for its NITRO (Novel Innovations for Tissue Regeneration in Osteoarthritis) program, which seeks proposals that will revolutionize the treatment and management of osteoarthritis (OA) by developing novel techniques

The Department of Commerce’s CHIPS (Creating Helpful Incentives to Produce Semiconductors) Program Office has garnered significant attention from potential investors and stakeholders across the United States. With a focus on expanding semiconductor production capabilities in the country, the CHIPS Program Office has already received over 300 statements of interest (SOIs) from various applicants representing 37

To obtain research funding through the federal government, you typically need to follow a series of steps. Here’s a general guide on how to navigate the process: Identify Funding Agencies: Start by identifying federal agencies that offer research funding relevant to your field of study or research area. Some prominent funding agencies include the National

DTRA Funding Alert: Amendment to DTRA Chemical / Biological Technologies Broad Agency Announcement Includes Additional Funding Opportunities to Develop Bioinformatics Capabilities, Ocular Sampling Technologies, and MCMs for Chemical Warfare Agents On March 21, 2023, the Defense Threat Reduction Agency (DTRA) released an amendment to the current Broad Agency Announcement (BAA) seeking proposals that address the

New Funding Opportunities Available Through the New Advanced Research Projects Agency for Health (ARPA-H) BAA ARPA-H, or the Advanced Research Projects Agency for Health, is an agency within the National Institutes of Health (NIH) that aims to accelerate the development of breakthrough technologies and treatments for major diseases. ARPA-H has been likened to the Defense

Amendment to BAA Outlines New DTRA Funding Opportunities to Develop Novel Technologies and Medical Countermeasures Against Weapons of Mass Destruction (WMD) and Emerging Threats The Defense Threat Reduction Agency (DTRA) recently published an amendment to their Broad Agency Announcement (‘BAA”) No. HDTRA1-22-S-0003, which provides additional funding opportunities to identify and counter Weapons of Mass Destruction

New Strategy Leads to New Funding Opportunities for the Development of Medical Countermeasures In the wake of the Coronavirus Disease 2019 (COVID-19) pandemic and a rapidly expanding landscape of biological and chemical threats, the Department of Defense (DoD) is initiating a new approach to developing Medical Countermeasures (MCM) for Joint Force protection. The Office of